Showing posts with label Warnings. Show all posts
Showing posts with label Warnings. Show all posts

Saturday, 28 January 2012

Shrader & Associates Investigates SimplyThick Recall Following FDA Warnings

Houston, TX (PRWEB) June 11, 2011

On May 20, 2011, the FDA issued an official warning stating that the "FDA Warns Not to Feed SimplyThick to Premature Infants". This official warning came before an FDA inspection of the food processing plant in Stone Mountain, Georgia where the product is manufactured. During this inspection, it was discovered that the plant did not perform a process required to kill harmful bacteria within the product. This warning was the official start of a still-ongoing investigation in which the bacterial contamination disease necrotizing enterocolitis (NEC) was discovered in 15 infants who were given the product. Two of the infants have died at this time. Further instances of necrotizing enterocolitis (NEC) may have occurred in a number of other yet to be reported cases. For more information on this product recall, please contact Shrader & Associates at 888-637-6236 or visit http://www.shraderlaw.com.


On June 5, 2011, two weeks after the FDA warning http://www.fda.gov/NewsEvents/newsroom/PressAnnouncements/ucm256253.htm was issued, Simply Thick, LLC, announced the voluntary recall of products that were manufactured on their behalf by Thermo Pac, LLC at the food processing plant located in Stone Mountain, Georgia. At this time, Simply Thick, LLC has voluntarily recalled only products made at the Stone Mountain, Georgia food processing plant. Shrader & Associates a national law firm specializing in product recalls and product liability provides the most recent recall information to clients and other interested persons at http://www.shraderlaw.com/simplythick-recall-advisory.


Current Recall Information


?At this time, the affected Simply Thick product could be in the homes of thousands,? warn product safety attorneys at Shrader & Associates. The Simply Thick, LLC recall includes products from the Stone Mountain, GA plant, which distributes the product across the United States and Canada. The SimplyThick product was placed in retail outlets, sold by drug distributors, sold by food service distributors, was provided to medical facilities including doctor's offices and hospitals, and was sold directly to consumers in stores.


FDA press release with Simply Thick, LLC recall product information may be found at http://www.fda.gov/Safety/Recalls/ucm257841.htm


While these are, at the current time, the only product lots known to be affected, future recalls are always possible and it is imperative that any person who has purchased this product use extreme caution with it, and keep a close watch for any SimplyThick side effects. The FDA investigation is still ongoing, and the total number of affected products is yet unknown. The number of infants harmed or killed is likewise unknown at this time.


Necrotizing Enterocolitis (NEC)


The bacterial contamination disease known as necrotizing enterocolitis causes the tissue in the intestines to become inflamed, and then die as a result of the extreme inflammation. In a premature infant, whose defenses are still developing, necrotizing enterocolitis can cause severe illness and death, as in the two dead infants discovered thus far in the FDA investigation. When products such as SimplyThick are manufactured, very rigid safety standards, set in place by the FDA, must be strictly observed to avoid any type of bacterial contamination. There is more information from Shrader & Associates about necrotizing enterocolitis at http://www.shraderlaw.com/necrotizing-enterocolitis-simplythick-side-effect.


Shrader & Associates, LLP fights for the rights of families who have been affected by necrotizing enterocolitis (NEC). Because safety standards were not followed, as in the case of the Simply Thick recall, thousands of infants could potentially be affected. Any person who needs to learn more about the SimplyThick recall, or necrotizing enterocolitis (NEC) side effects is urged to contact the attorneys of Shrader & Associates who specialize in product liability and product recalls at 888-637-6236, or visits us on the web at http://www.shraderlaw.com/simplythick-recall-advisory for help with their case.


For More Information: http://www.ShraderLaw.com


###





Swedish Study Adds Further Weight to Eludril and Elgydium Gum Disease Warnings

Bournemouth, Dorset (PRWEB) December 14, 2011

New research from Sweden into gum disease adds further weight to concerns over its links with more serious medical conditions, warn the experts at Eludril and Elgydium.


Bleeding gums ? which some people foolishly dismiss as a common occurrence ? have been identified as an important health warning sign in the new Swedish study.


People with the highest incidence of bleeding gums are more likely to suffer from a stroke than those with the lowest incidence, said the Centre for Research and Development of the County Council of G?vleborg, Sweden.


Its study of around 8,000 people has produced a series of potential health risk indicators:

????People with fewer than 21 teeth had a 69 per cent higher risk of heart attack compared with those with the most teeth.
????Higher numbers of deep periodontal pockets (gum infection around the base of the tooth) had a 53 per cent higher risk of heart attack compared with those with the fewest pockets.
????People with the least teeth had an increased risk of congestive heart failure compared with those with the most.

The Swedish study echoes similar research presented to the American Heart Association which showed that people who have their teeth cleaned by dentists or hygienists at least every 12 months are 25 per cent less likely to suffer a heart attack.


Both sets of research back up oral health care advice given by the manufacturers of the medicinal products Eludril mouthwash and Elgydium toothpaste.


A spokesman for Elgydium and Eludril said: ?The new Swedish study is yet more evidence of the correlation between gum disease and more serious medical conditions.


?Increasing numbers of studies are pointing to the link, highlighting the importance of adopting a good oral health care regime and sticking to it.?


During the last two years there have been at least 146 clinical trials relating to gum disease in the United States alone with 72 more in Europe, 26 in the Middle East, 22 in South America plus several dozen more in the rest of the world.


The correlation between gum disease and cardiac conditions has been suggested for a number of years and latest research continues to back this up.


Lack of attention to basic oral health care, such as brushing and flossing, results in plaque which then leads to bacteria and gum disease.


Even seemingly minor gum disease symptoms could be an early indication of more serious medical problems later in life.


Typical early signs of gum disease include swollen gums, a prelude to more pressing symptoms.


Sore gums should be sufficient reason to go to the dentist and tackle the problem quickly before it worsens but some people suffer in silence instead.


Ignoring these early stages can result in receding gums which not only jeopardises the teeth ? it leaves the body vulnerable to more serious medical problems caused by bacteria and infections.


Using a medicinal toothpaste such as Elgydium every day helps to ward off plaque and the signs of gum disease.


Elgydium contains the active ingredient chlorhexidine, widely regarded by dentists and hygienists around the world as the leading gingivitis treatment.


Tried and tested chlorhexidine ? which has been used since the 1980s ? is also one of the active ingredients in Eludril, a leading medicinal mouthwash developed to help combat gum disease.


Eludril is a menthol-flavoured mouthwash that is recommended as a short-term treatment for gum disease. One rinse can keep working for up to 12 hours.


Dental professionals recommend a 15ml dosage (for adults and children aged over 6) diluted with lukewarm water using the measuring cup provided.


Discover how Elgydium and Eludril can help to stop gum disease. Contact Nikki Pounds at Ceuta Healthcare on +44 (0)1202 780558.


Notes For Editors


Eludril and Elgydium are represented in the UK by:

Ceuta Healthcare Ltd

Hill House

41 Richmond Hill

Bournemouth

Dorset

BH2 6HS

Tel: +44 (0)1202 780558


Eludril Mouthwash is an antibacterial and analgesic solution which can be used to manage a number of oral health problems.


Its main use is to treat and prevent dental plaque formation and gum disease (gingivitis, also known as periodontitis) by preventing the build-up of bacteria.


Eludril Mouthwash can also be used to maintain oral hygiene in situations where tooth brushing is difficult, for instance, following oral surgery or in physically or mentally handicapped patients.


Eludril can also be used as a disinfectant for the cleansing of removable dentures and in the management of common mouth ulcers and oral candidiasis infections (fungus infections).


Elgydium Anti-Plaque toothpaste is specially formulated for sensitive gums and helps to prevent dental plaque and tartar build-up, the major causes of tooth decay and gum disease.


Elgydium Whitening, Sensitive and Decay Protection are also available as part of the Elgydium range of toothpastes.


###